Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1986 studies found for:    Open Studies | "Hematologic Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
Conditions: Hematologic Diseases;   Healthy Volunteers
Intervention: Genetic: Isolation of genomic DNA
2 Recruiting Integrated Whole-Genome Analysis of Hematologic Disorders
Condition: Hematologic Diseases
Interventions: Procedure: Blood Draw;   Procedure: Skin Biopsy
3 Recruiting Evaluation of Patients With Blood Disorders
Condition: Hematologic Disease
Intervention:
4 Recruiting Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
Conditions: Febrile Neutropenia;   Hematological Diseases
Interventions: Drug: Micafungin sodium;   Drug: Itraconazole
5 Recruiting Evaluation, Treatment, and Training for Patients With Blood Disorders
Conditions: Hematologic Disease;   Hematologic Neoplasm;   Pancytopenia
Intervention:
6 Recruiting Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow
Conditions: Hematologic Disease;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndrome;   Myeloproliferative Disorder
Intervention: Procedure: Stem cell transplantation
7 Recruiting Stem Cell Transplant for Patients With Sickle Cell Disease (SCD), Thalassemia, Diamond Blackfan Anemia (DBA) and Other Non-malignant (Non-cancerous) Hematologic Disorders
Conditions: Sickle Cell Disease;   Thalassemia;   Diamond Blackfan Anemia;   Non-malignant Hematologic Disorders
Interventions: Drug: Anti-thymocyte globulin (ATG);   Drug: Fludarabine monophosphate;   Drug: Busulfan;   Drug: Alemtuzumab;   Drug: Cyclophosphamide;   Drug: Mesna;   Radiation: total body irradiation
8 Recruiting Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery
Conditions: Blood and Blood Disorders;   Anemia, Neonatal;   Hematologic Disease;   Infant, Newborn, Diseases
Intervention: Procedure: Fetoscopic laser surgery
9 Unknown  Registry of Febrile Neutropenia and Invasive Fungal Infections
Conditions: Hematological Disease;   Febrile Neutropenia;   Fungal Infections
Intervention: Other: Patient registry
10 Unknown  Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases
Condition: Febrile Neutropenia
Interventions: Drug: ciprofloxacin;   Drug: cefepime
11 Recruiting Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
Conditions: Hematological Diseases;   Thrombocytopenia
Interventions: Biological: MPs;   Drug: thrombopoietin (TPO) and interleukin-11
12 Recruiting Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
Condition: Hematologic Disorder
Interventions: Drug: Lenalidomide;   Biological: Influenza Vaccine;   Biological: Pneumovax Vaccine
13 Recruiting SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)
Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma;   Lymphoma, Primary Cutaneous Anaplastic Large Cell;   Lymphomatoid Papulosis;   Mycosis Fungoides;   Skin Lymphoma;   Cutaneous Lymphomas;   Lymphoma;   Hematologic Disorder
Intervention: Drug: SGN-35
14 Recruiting Dexamethasone Dyspnea Study
Conditions: Advanced Cancers;   Hematologic Disorder;   Solid Tumors
Interventions: Drug: Dexamethasone;   Drug: Placebo;   Behavioral: Questionnaires;   Device: Spirometer;   Other: Phone Calls
15 Recruiting Transplants With Unlicensed Preserved Cord Blood
Conditions: Myelodysplastic Syndrome (MDS);   Hematologic Neoplasms;   Hematologic Diseases;   Severe Aplastic Anemia
Intervention: Procedure: Cord Blood Transplant
16 Recruiting A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Conditions: Primary Myelofibrosis;   Thrombocythemia, Essential;   Thrombocytosis;   Myeloproliferative Disorders;   Bone Marrow Diseases;   Hematologic Diseases;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hemorrhagic Disorders
Interventions: Drug: LDE225;   Drug: INC424
17 Unknown  Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation
Condition: Hematologic Diseases
Intervention: Drug: Everolimus and mycophenolate sodium
18 Unknown  A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
Conditions: Anemia;   Intestinal Helminthiasis;   Intestinal Schistosomiasis;   Human Immunodeficiency Virus I Infection;   Hematologic Diseases;   Opportunistic Infections
Intervention: Drug: Praziquantel and Albendazole
19 Recruiting Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.
Conditions: Leukemia;   Leukemia,Pediatric;   Leukemia, Myleiod;   Leukemia, Mylegenous, Chronic;   Leukemia, Mylegenous, Accelerated;   BCR-ABL Positive;   Myeloproliferative Disorder;   Bone Marrow Disease;   Hematologic Diseases;   Neoplastic Processes;   Imatinib;   Dasatinib;   Enzyme Inhibitor;   Protein Kinase Inhibitor
Intervention: Drug: nilotinib
20 Recruiting Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
Condition: Hematologic Diseases
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years